Zee Laboratories supplies medicines to government hospitals and institutions such as AIIMS, as well as to central and state ...
Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...
Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...
Arsenale Bioyards standardizes biomanufacturing from the industrial side, aiming to make biopharmaceutical manufacturing efficient, scalable, and cost-effective, much as the Bessemer converter did for ...
Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system. “With ...
The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
BioNTech has already been tinkering with its manufacturing processes in the run up to CAR-T BNT211 entering pivotal trials. Now, the German biotech has brought British company Autolus Therapeutics on ...
Residues of pharmaceutical products can enter the environment during the manufacturing process, during usage, and disposal. With the growing trend in sustainable practices, the translation of ...
VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...
Trinity Biotech plc, a biotechnology company focusing on human diagnostics and diabetes management, has announced a significant update to its Comprehensive Transformation Plan, which includes ...
Houston-based clinical-stage biotechnology company FibroBiologics Inc. opened a manufacturing laboratory at 9350 Kirby Drive in the Texas Technology Park. It will bring manufacturing operations ...
Leveraging Northway Biotech's 20+ years of CDMO expertise, Diorasis Therapeutics is advancing DT003, a single-dose AAV gene therapy for glaucoma. As part of the collaboration, Northway Biotech will ...